The effect of HIF-1α siRNA on growth and chemosensitivity of mia-paca cell line

Yonsei Medical Journal

Volumn 49, Issue 2, 2008, Pages 295-300

  Yang, Lily ^a   Kang, Won Kyung ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Catholic University of Korea   (South Korea)

Author keywords

Hypoxia Inducible Factor 1 alpha; Small interfering RNA pancreatic neoplasms

Indexed keywords

ANTIBIOTIC G 418; CASPASE 3; GEMCITABINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLASMID VECTOR; SMALL INTERFERING RNA; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG TARGETING; ENZYME ASSAY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MONOTHERAPY; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; RNA INTERFERENCE; ANIMAL; CELL HYPOXIA; CELL SURVIVAL; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; RANDOMIZATION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BLOTTING, WESTERN; CASPASE 3; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DEOXYCYTIDINE; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; RANDOM ALLOCATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 44649147928     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.2.295     Document Type: Article

References (15)

1. Déry MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005;37:535-40.
2. Bae SH, Jeong JW, Park JA, Kim SH, Bae MK, Choi SJ, et al. Sumoylation increases HIF-1alpha stability and its transcriptional activity. Bioche mBiophys Res Commun 2004;324:394-400
3. Zagórska A, Dulak J. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim Pol 2004;51:563-85.
4. Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004;3:318-29.
5. Ryther RC, Flynt AS, Phillips JA 3rd, Patton JG. siRNA therapeutics: big potential from small RNAs. Gene Ther 2005;12:5-11.
6. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
7. Bold RJ, Chandra J, McConkey DJ. Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content. Ann Surg Oncol 1999;6:279-85.
8. Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, et al. Silencing hypoxia-inducible factor-1alpha ird-dbits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 2007;30:793-802.
9. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-7.
10. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 2004;53:153-9.
11. Karagiannis TC, El-Osta A. siRNAs: mechanism of RNA interference, in vivo and potential clinical applications. Cancer Biol Ther 2004,3:1069-74.
12. Chang HS, Lin CH, Chen YC, Yu WC. Using siRNA technique to generate transgenic animals with spatio-temporal and conditional gene knockdown. Am J Pathol 2004;165:1535-41.
13. Hsieh AC, Bo R, Manola J, Vazquez F, Bare O, Khvorova A, et al. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res 2004;32:893-901.
14. Zhao Q, Du J, Gu H, Teng X, Zhang Q, Qin H, et al. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Pancreas 2007;34:242-7.
15. Yang L, Cao Z, Li F, Post DE, Van Meir EG, Zhong H, et al. Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Ther 2004;11:1215-23.